Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET

NCT01699828 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT01699828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01699828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET
Lead sponsor
Centre for Addiction and Mental Health
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2012
Completion date
June 30, 2014
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation, tobacco use cessation